U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C36H62O31
Molecular Weight 990.8589
Optical Activity UNSPECIFIED
Defined Stereocenters 30 / 30
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of O-α-D-Galactopyranosyl-(1→2)-O-[β-D-galactopyranosyl-(1→3)]-O-α-D-galactopyranosyl-(1→3)-O-β-D-galactofuranosyl-(1→3)-O-β-D-glucopyranosyl-(1→5)-β-D-galactofuranose

SMILES

[H][C@@]3(O[C@@]1([H])[C@H](O)[C@@H](CO)O[C@@H](O[C@H](CO)[C@]2([H])O[C@@H](O)[C@H](O)[C@H]2O)[C@@H]1O)O[C@@]([H])([C@H](O)CO)[C@]([H])(O[C@@]4([H])O[C@H](CO)[C@H](O)[C@]([H])(O[C@]5([H])O[C@H](CO)[C@H](O)[C@H](O)[C@H]5O)[C@@]4([H])O[C@@]6([H])O[C@H](CO)[C@H](O)[C@H](O)[C@H]6O)[C@H]3O

InChI

InChIKey=PFHODIHMQTXSDG-UEMLJMBFSA-N
InChI=1S/C36H62O31/c37-1-7(43)25-29(24(55)35(63-25)64-27-15(46)10(4-40)59-34(23(27)54)61-12(6-42)26-19(50)20(51)31(56)62-26)66-36-30(67-33-22(53)18(49)14(45)9(3-39)58-33)28(16(47)11(5-41)60-36)65-32-21(52)17(48)13(44)8(2-38)57-32/h7-56H,1-6H2/t7-,8-,9-,10-,11-,12-,13+,14+,15-,16+,17+,18+,19-,20-,21-,22-,23-,24-,25+,26+,27+,28+,29-,30-,31-,32+,33-,34+,35+,36-/m1/s1

HIDE SMILES / InChI

Approval Year

Name Type Language
O-α-D-Galactopyranosyl-(1→2)-O-[β-D-galactopyranosyl-(1→3)]-O-α-D-galactopyranosyl-(1→3)-O-β-D-galactofuranosyl-(1→3)-O-β-D-glucopyranosyl-(1→5)-β-D-galactofuranose
Common Name English
β-D-Galactofuranose, O-α-D-galactopyranosyl-(1→2)-O-[β-D-galactopyranosyl-(1→3)]-O-α-D-galactopyranosyl-(1→3)-O-β-D-galactofuranosyl-(1→3)-O-β-D-glucopyranosyl-(1→5)-
Common Name English
Code System Code Type Description
CAS
875800-02-5
Created by admin on Sat Dec 16 19:57:40 GMT 2023 , Edited by admin on Sat Dec 16 19:57:40 GMT 2023
PRIMARY
FDA UNII
YHE8YR9LSC
Created by admin on Sat Dec 16 19:57:40 GMT 2023 , Edited by admin on Sat Dec 16 19:57:40 GMT 2023
PRIMARY